Literature DB >> 10751330

Coordinate expression of secretory phospholipase A(2) and cyclooxygenase-2 in activated human keratinocytes.

K E Rys-Sikora1, R L Konger, J W Schoggins, R Malaviya, A P Pentland.   

Abstract

PGE(2) levels are altered in human epidermis after in vivo wounding; however, mechanisms modulating PGE(2) production in activated keratinocytes are unclear. In previous studies, we showed that PGE(2) is a growth-promoting autacoid in human primary keratinocyte cultures, and its production is modulated by plating density, suggesting that regulated PGE(2) synthesis is an important component of wound healing. Here, we examine the role of phospholipase A(2) (PLA(2)) and cyclooxygenase (COX) enzymes in modulation of PGE(2) production. We report that the increased PGE(2) production that occurs in keratinocytes grown in nonconfluent conditions is also observed after in vitro wounding, indicating that similar mechanisms are involved. This increase was associated with coordinate upregulation of both COX-2 and secretory PLA(2) (sPLA(2)) proteins. Increased sPLA(2) activity was also observed. By RT-PCR, we identified the presence of type IIA and type V sPLA(2), along with the M-type sPLA(2) receptor. Thus the coordinate expression of sPLA(2) and COX-2 may be responsible for the increased prostaglandin synthesis in activated keratinocytes during wound repair.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751330     DOI: 10.1152/ajpcell.2000.278.4.C822

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

1.  Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation.

Authors:  Kausar M Ansari; Joyce E Rundhaug; Susan M Fischer
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

2.  Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation.

Authors:  Hiroyasu Sato; Yoshitaka Taketomi; Yuki Isogai; Seiko Masuda; Tetsuyuki Kobayashi; Kei Yamamoto; Makoto Murakami
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

3.  The EP1 subtype of prostaglandin E2 receptor: role in keratinocyte differentiation and expression in non-melanoma skin cancer.

Authors:  R L Konger; S D Billings; N C Prall; T M Katona; S C Dasilva; C R J Kennedy; S Badve; S M Perkins; P T Lacelle
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-07-22       Impact factor: 4.006

4.  Syntheses of prostaglandin E2 and E-cadherin and gene expression of beta-defensin-2 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans.

Authors:  Takuji Noguchi; Hideki Shiba; Hitoshi Komatsuzawa; Noriyoshi Mizuno; Yuushi Uchida; Kazuhisa Ouhara; Ryuji Asakawa; Seiji Kudo; Hiroyuki Kawaguchi; Motoyuki Sugai; Hidemi Kurihara
Journal:  Inflammation       Date:  2003-12       Impact factor: 4.092

5.  Induction of cellular senescence by secretory phospholipase A2 in human dermal fibroblasts through an ROS-mediated p53 pathway.

Authors:  Hyun Jung Kim; Kwang Seok Kim; Si Hyung Kim; Suk-Hwan Baek; Hwa Young Kim; ChuHee Lee; Jae-Ryong Kim
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-03-04       Impact factor: 6.053

6.  Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin.

Authors:  M Amigó; M Payá; S De Rosa; M C Terencio
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

7.  From a traditional medicinal plant to a rational drug: understanding the clinically proven wound healing efficacy of birch bark extract.

Authors:  Sandra Ebeling; Katrin Naumann; Simone Pollok; Tina Wardecki; Sabine Vidal-Y-Sy; Juliana M Nascimento; Melanie Boerries; Gudula Schmidt; Johanna M Brandner; Irmgard Merfort
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.